格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助,这一举措是为了研究口服免疫疗法的给药方案,以供美国军队使用。Immuron是一家处于临床阶段的医疗公司,专注于一种新型特异性... 网页链接
$免疫子制药(IMRN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002207 Act: 33 Size: 1 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-062303 Act: 34 Size: 4 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-061171 Act: 34 Size: 99 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-059911 Act: 34 Size: 5 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-059244 Act: 34 Size: 58 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058780 Act: 34 Size: 297 KB 网页链接
$免疫子制药(IMRN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058720 Act: 33 Size: 953 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058180 Act: 34 Size: 167 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-049849 Act: 34 Size: 52 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-048181 Act: 34 Size: 13 MB 网页链接